If GLP-1 therapy is initiated , a structured monitoring plan should include: Regular assessment of weight, BMI and nutritional status Monitoring of hydration and renal function, particularly if experiencing significant gastrointestinal symptoms For diabetes patients, appropriate retinopathy surveillance if glycaemic control improves rapidly (especially with semaglutide) [5] [11] Regular review of Crohn's disease activity using clinical and biochemical markers Remember that you are an active participant in your healthcare decisions, and your concerns and experiences should guide the treatment plan
For many seniors, the result is improved energy, clearer thinking, and fewer falls or ER
Age-specific differential changes on gut microbiota composition in patients with major depressive disorder
It helps lower blood sugar, delay emptying of the stomach, and regulate appetite
Encourages blood vessel growth, wound healing, and recovery from inflammation-related skin or tissue damage
Start your intake How GLP-1 Medications Affect Digestive Function GLP-1 receptor agonists slow gastric emptying and increase satiety by activating receptors throughout the gastrointestinal tract